Clinical trial: Ultra-High Resolution PET of the Human Brain and Spinal Cord in Healthy Aging, Dementia, Movement Disorders, ALS and Psychotic Disorders

https://clinicaltrials.gov/study/NCT07509125?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20361

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Evaluating the Feasibility and Effectiveness of an Online Psychological Intervention Targeting Problem-Solving and Coping Strategies in People With Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07507149?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20353

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: An Exploratory Clinical Study Evaluate the Safety and Efficacy of Universal Universal Allogeneic CAR-T Cells Targeting CD19 and BCMA in the Treatment of B Cell-Related Autoimmune Disease

https://clinicaltrials.gov/study/NCT07507201?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20354

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07507084?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20355

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Turkish Version of the Neurogenic Bladder Symptom Score Short Form: Cross-Cultural Adaptation and Validation-Reliability Study

https://clinicaltrials.gov/study/NCT07507331?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20356

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A Study Investigating Drivers of Physician and Patient Satisfaction Towards Treatment

https://clinicaltrials.gov/study/NCT07504783?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20348

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in People With Multiple Sclerosis With Mild Disability

https://clinicaltrials.gov/study/NCT07505355?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20349

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: An Open-label Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07503340?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20338

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A Phase 2, Multicenter, Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector Device Versus Syringe in Patients With Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07503873?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20339

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Superpower Aims for FDA Approval of Peptides

Superpower Medical will test peptides like epitalon and BPC-157 in new trials. They hope to get FDA approval for these wellness compounds.

#PeptideTherapy, #FDA, #ClinicalTrials, #Epitalon, #BPC157

https://newsletter.tf/superpower-medical-fda-peptide-trials/